Breaking News
This is the future we shall bring into being
Elon Musk's Vision For The Future Looks Like A Movie
Phosphorus Munitions Fired by Israel Burn Groves, Orchards in Southern Lebanon
Iran's IRGC Warns It Will Expand 'Geography of the War' If the US Attacks Again
Top Tech News
BEYOND THE MOON: NASA plans a nuclear-powered fleet to push DEEPER into space
Big Oil Backs Mazama's $135 Million Bet On Superhot Geothermal
Quantum compass takes flight on Northrop's Lumberjack drone
Terrifying AI Behavior Even Its Creators Couldn't Explain
WW3 Near-Miss? AI Hallucinated Nuclear Weapons Components Aboard Chinese Vessel Bound For Iran
Stripe Is Building the Toll Road for the Machine Economy
Toyota Dakar hopeful swaps twin-turbo V6 for hydrogen fuel cells
4-min turbo-inflatable cubic camp castle is now available in the USA
Researchers Used Claude To Hack OpenAI Employee Accounts
Chinese Scientists Develop New Oil Refining Method That Cuts Energy Use by 90%
Breakthrough cancer drug could be astronomical in price
"It is a revolutionary treatment," said Dr. Prakash Satwani, a pediatric hematologist at NewYork-Presbyterian/Columbia University Medical Center, noting that the therapy can help some leukemia patients with no other options. But, he added, "the price will be phenomenal."
"From what we're hearing, this will be a quantum leap more expensive than other cancer drugs," said Leonard Saltz, chief of gastrointestinal oncology at Memorial Sloan Kettering Cancer Center in New York.
Switzerland-based Novartis hasn't announced a price for the medicine, but British health authorities have said a price of $649,000 for a one-time treatment would be justified, given the significant benefits.
The cancer therapy was unanimously approved by a Food and Drug Administration advisory committee in July, and its approval seems all but certain.